Skip to main content
Top

2004 | OriginalPaper | Hoofdstuk

3 Doorgaan of stoppen?

Antipsychotica bij ambulante patiënten die een vroege psychose hebben doorgemaakt

Auteur : Pieter Vlaminck

Gepubliceerd in: Dilemma’s in de psychiatrische praktijk

Uitgeverij: Bohn Stafleu van Loghum

share
DELEN

Deel dit onderdeel of sectie (kopieer de link)

  • Optie A:
    Klik op de rechtermuisknop op de link en selecteer de optie “linkadres kopiëren”
  • Optie B:
    Deel de link per e-mail

Samenvatting

De ambulante behandeling van een jonge volwassene die voor het eerst psychotisch is, kan in veel gevallen vrij eenvoudig zijn. De psychiater schrijft een antipsychoticum voor in een lage dosering, hij heeft met de patiënt een aantal gesprekken over de inhoud en de betekenis van de psychotische ervaringen en hij biedt, waar nodig en gewenst, steun en voorlichting aan de familie. Na een paar maanden zal de psychose in veel gevallen redelijk onder controle zijn. De vraag wordt dan al gauw hoe het verder moet met de medicatie.
Literatuur
go back to reference American Psychiatrie Association (1994). Diagnostic and statistical manual of mental disorders, fourth edition. Washington, APA. American Psychiatrie Association (1994). Diagnostic and statistical manual of mental disorders, fourth edition. Washington, APA.
go back to reference American Psychiatrie Association (1997). Practice guideline for the treatment of patients with schizophrenia. The American Journal of Psychiatry, 154(4), supplement, 1–63.CrossRef American Psychiatrie Association (1997). Practice guideline for the treatment of patients with schizophrenia. The American Journal of Psychiatry, 154(4), supplement, 1–63.CrossRef
go back to reference Beasley, C.M. e.a. (1999). Randomised double-blind comparison of the incidence of tardive dyskinesia in patients with schizophrenia during long-term treatment with olanzapine or haloperidol. British Journal of Psychiatry, 174, 23–30.CrossRefPubMed Beasley, C.M. e.a. (1999). Randomised double-blind comparison of the incidence of tardive dyskinesia in patients with schizophrenia during long-term treatment with olanzapine or haloperidol. British Journal of Psychiatry, 174, 23–30.CrossRefPubMed
go back to reference Blom, J.D. (2003). Deconstructing schizophrenia. Academisch proefschrift. Amsterdam. Blom, J.D. (2003). Deconstructing schizophrenia. Academisch proefschrift. Amsterdam.
go back to reference Casey, D.E. (1995). Acute extrapyramidal syndromes. In: C.L. Shriqui & H.A. Nasrallah (eds.), Contemporary issues in the treatment of schizophrenia. Washington DC: American Psychiatric Press. Casey, D.E. (1995). Acute extrapyramidal syndromes. In: C.L. Shriqui & H.A. Nasrallah (eds.), Contemporary issues in the treatment of schizophrenia. Washington DC: American Psychiatric Press.
go back to reference Coldham, E.L., Addington, J., & Addington, D. (2002). Medication adherence of individuals with a first episode of psychosis. Acta Psychiatrica Scandinavica, 106, 286–290.CrossRefPubMed Coldham, E.L., Addington, J., & Addington, D. (2002). Medication adherence of individuals with a first episode of psychosis. Acta Psychiatrica Scandinavica, 106, 286–290.CrossRefPubMed
go back to reference Crow, T.J. e.a. (1986). The Northwick Park Study of first episodes of schizophrenia. II. A randomi- zed controlled trial of prophylactic neuroleptic treatment. British Journal of Psychiatry, 148, 120–127.CrossRefPubMed Crow, T.J. e.a. (1986). The Northwick Park Study of first episodes of schizophrenia. II. A randomi- zed controlled trial of prophylactic neuroleptic treatment. British Journal of Psychiatry, 148, 120–127.CrossRefPubMed
go back to reference Csernansky, J.G. e.a. (2002). A comparison of risperidone and haloperidol for the prevention of relapse in patients with schizophrenia. The New England Journal of Medicine, 346, 16–22.CrossRefPubMed Csernansky, J.G. e.a. (2002). A comparison of risperidone and haloperidol for the prevention of relapse in patients with schizophrenia. The New England Journal of Medicine, 346, 16–22.CrossRefPubMed
go back to reference Dolder, C.R. e.a. (2002). Antipsychotic medication adherence: is there a difference between typical and atypical agents? American Journal of Psychiatry, 159, 103–108.CrossRefPubMed Dolder, C.R. e.a. (2002). Antipsychotic medication adherence: is there a difference between typical and atypical agents? American Journal of Psychiatry, 159, 103–108.CrossRefPubMed
go back to reference Gaebel, W. e.a. (2002). First versus multiple episode schizophrenia: two-year outcom of intermittent and maintenance medication strategies. Schizophrenia Research, 53, 145–159.CrossRefPubMed Gaebel, W. e.a. (2002). First versus multiple episode schizophrenia: two-year outcom of intermittent and maintenance medication strategies. Schizophrenia Research, 53, 145–159.CrossRefPubMed
go back to reference Giel, R. (1995). Voorkomen en beloop van schizofrenie. In: P. Dingemans e.a. (red.), Schizofrenie. Houten/Diegem: Bohn Stafleu Van Loghum. Giel, R. (1995). Voorkomen en beloop van schizofrenie. In: P. Dingemans e.a. (red.), Schizofrenie. Houten/Diegem: Bohn Stafleu Van Loghum.
go back to reference Gilbert, P.L. e.a. (1995). Neuroleptic withdrawal in schizophrenic patients. Archives of General Psychiatry, 52, 173–212.CrossRefPubMed Gilbert, P.L. e.a. (1995). Neuroleptic withdrawal in schizophrenic patients. Archives of General Psychiatry, 52, 173–212.CrossRefPubMed
go back to reference Haan, L. de, & Maksmovic, I. (1999). Psychosebehandeling met een lage dosering D2-antagonist. Tijdschrift voor Psychiatrie, 41, 287–291. Haan, L. de, & Maksmovic, I. (1999). Psychosebehandeling met een lage dosering D2-antagonist. Tijdschrift voor Psychiatrie, 41, 287–291.
go back to reference Harten, P.N. van (1998). Movement disorders associated with neuroleptics. Proefschrift universiteit Utrecht. Harten, P.N. van (1998). Movement disorders associated with neuroleptics. Proefschrift universiteit Utrecht.
go back to reference Henderson, D.C. (2000). Clozapine, diabetes mellitus, weight gain and lipid abnormalities: a five-year naturalistic study. American Journal of Psychiatry, 157, 975–981.CrossRefPubMed Henderson, D.C. (2000). Clozapine, diabetes mellitus, weight gain and lipid abnormalities: a five-year naturalistic study. American Journal of Psychiatry, 157, 975–981.CrossRefPubMed
go back to reference Herz M.I., & Lamberti, J.S. (1995). Prodromal symptoms and relapse prevention in schizophrenia. Schizophrenia Bulletin, 4, 541–551.CrossRef Herz M.I., & Lamberti, J.S. (1995). Prodromal symptoms and relapse prevention in schizophrenia. Schizophrenia Bulletin, 4, 541–551.CrossRef
go back to reference Johnstone, E.C. e.a. (1990). Further investigation of the predictors of outcome following first schizophrenic episodes. British Journal of Psychiatry, 157, 182–189.CrossRefPubMed Johnstone, E.C. e.a. (1990). Further investigation of the predictors of outcome following first schizophrenic episodes. British Journal of Psychiatry, 157, 182–189.CrossRefPubMed
go back to reference Jørgensen, P. e.a. (1997). Acute and transient psychotic disorder: a 1-year follow-up study. Acta Psychiatrica Scandinavica, 96, 150–154.CrossRefPubMed Jørgensen, P. e.a. (1997). Acute and transient psychotic disorder: a 1-year follow-up study. Acta Psychiatrica Scandinavica, 96, 150–154.CrossRefPubMed
go back to reference Kopala, L.C., Good, K.P., & Honer, W.G. (1997). Extrapyramidal signs and clinical symptoms in first-episode schizophrenia: response to low-dose risperidone. Journal of Clinical Psychopharmacology, 37, 308–313.CrossRef Kopala, L.C., Good, K.P., & Honer, W.G. (1997). Extrapyramidal signs and clinical symptoms in first-episode schizophrenia: response to low-dose risperidone. Journal of Clinical Psychopharmacology, 37, 308–313.CrossRef
go back to reference Kuipers, L. e.a., (1998). Werken met gezinnen bij schizofrenie. Utrecht, Uitgeverij SWP. Kuipers, L. e.a., (1998). Werken met gezinnen bij schizofrenie. Utrecht, Uitgeverij SWP.
go back to reference Lunbeck (anoniem) (1996). Prelapseprogramma. Lunbeck (anoniem) (1996). Prelapseprogramma.
go back to reference MacMillan, J.F. e.a. (1986). The Northwick Park Study of first episodes of schizophrenia. III. Short- term outcome in trial entrants and trial eligible patients. British Journal of Psychiatry, 148, 128–133.CrossRefPubMed MacMillan, J.F. e.a. (1986). The Northwick Park Study of first episodes of schizophrenia. III. Short- term outcome in trial entrants and trial eligible patients. British Journal of Psychiatry, 148, 128–133.CrossRefPubMed
go back to reference Meer, R. van (1995). Leven met schizofrenie. Amsterdam, Sijthoff. Meer, R. van (1995). Leven met schizofrenie. Amsterdam, Sijthoff.
go back to reference Meijel, B. van e.a. (1998). Vroegsignalering en vroege interventie bij patienten met schizofrenie. Maandblad Geestelijke volksgezondheid, 53, 347–360. Meijel, B. van e.a. (1998). Vroegsignalering en vroege interventie bij patienten met schizofrenie. Maandblad Geestelijke volksgezondheid, 53, 347–360.
go back to reference Moleman, P. (1998). Praktische psychofarmacologie. Houten/Diegem: Bohn Stafleu Van Loghum. Moleman, P. (1998). Praktische psychofarmacologie. Houten/Diegem: Bohn Stafleu Van Loghum.
go back to reference Nederlandse Vereniging voor Psychiatrie (1998). Richtlijn antipsychoticagebruik bij schizofrene psychosen. Amsterdam: Boom. Nederlandse Vereniging voor Psychiatrie (1998). Richtlijn antipsychoticagebruik bij schizofrene psychosen. Amsterdam: Boom.
go back to reference Norman, R.M., & Malla, A.K. (1995). Prodromal symptoms and relapse in schizophrenia: a review. Schizophrenia Bulletin, 4, 527–539.CrossRef Norman, R.M., & Malla, A.K. (1995). Prodromal symptoms and relapse in schizophrenia: a review. Schizophrenia Bulletin, 4, 527–539.CrossRef
go back to reference Perkins, D.O. (1999). Adherence to antipsychotic medications. J. Clin. Psychiatry, 60(12), 25–30.PubMed Perkins, D.O. (1999). Adherence to antipsychotic medications. J. Clin. Psychiatry, 60(12), 25–30.PubMed
go back to reference Pocock, S.J. (1983). Clinical trials: a practical approach. Chicester: John Wiley & Sons. Pocock, S.J. (1983). Clinical trials: a practical approach. Chicester: John Wiley & Sons.
go back to reference Viguera, A.C. e.a. (1997). Clinical risk following abrupt and gradual withdrawal of maintenance neuroleptic treatment. Archives of General Psychiatry, 54, 49–55.CrossRefPubMed Viguera, A.C. e.a. (1997). Clinical risk following abrupt and gradual withdrawal of maintenance neuroleptic treatment. Archives of General Psychiatry, 54, 49–55.CrossRefPubMed
go back to reference Vlaminck, P. (2002). De ‘schizofrenie’ ontmanteld. Maanblad Geestelijke volksgezondheid, 57, 342–363. Vlaminck, P. (2002). De ‘schizofrenie’ ontmanteld. Maanblad Geestelijke volksgezondheid, 57, 342–363.
go back to reference Vlaminck, P. (2003). De moderne aanpak van de vroege psychose. Delft: Eburon. Vlaminck, P. (2003). De moderne aanpak van de vroege psychose. Delft: Eburon.
go back to reference Wells, K.B. (1999). Treatment research at the crossroads: the scientific interface of clinical trials and effectiveness research. American Journal of Psychiatry, 156, 5–10.CrossRefPubMed Wells, K.B. (1999). Treatment research at the crossroads: the scientific interface of clinical trials and effectiveness research. American Journal of Psychiatry, 156, 5–10.CrossRefPubMed
go back to reference WHO (1992). The ICD-10 classification of mental and behavioural disorders: clinical descriptions and diagnostic guidelines. Geneva: WHO. WHO (1992). The ICD-10 classification of mental and behavioural disorders: clinical descriptions and diagnostic guidelines. Geneva: WHO.
go back to reference Wiersma, T. (1999). Twee eeuwen zoeken naar medische bewijsvoering. De gespannen verhouding tussen experimentele fysiologie en klinische epidemiologie. Amsterdam: Boom/Belvedère. Wiersma, T. (1999). Twee eeuwen zoeken naar medische bewijsvoering. De gespannen verhouding tussen experimentele fysiologie en klinische epidemiologie. Amsterdam: Boom/Belvedère.
go back to reference Wulff, H.R., Pedersen, S.A., & Rosenberg, R. (1988). Filosofie van de geneeskunde. Utrecht: Bunge. Wulff, H.R., Pedersen, S.A., & Rosenberg, R. (1988). Filosofie van de geneeskunde. Utrecht: Bunge.
go back to reference Yassa, R., Nair, N.P.V., & Jeste, D.V. (1997). Neuroleptic-induced movement disorders. Cambridge: University Press. Yassa, R., Nair, N.P.V., & Jeste, D.V. (1997). Neuroleptic-induced movement disorders. Cambridge: University Press.
Metagegevens
Titel
3 Doorgaan of stoppen?
Auteur
Pieter Vlaminck
Copyright
2004
Uitgeverij
Bohn Stafleu van Loghum
DOI
https://doi.org/10.1007/978-90-313-9692-4_3